253 related articles for article (PubMed ID: 34365742)
1. CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming.
Tao L; Moreno-Smith M; Ibarra-García-Padilla R; Milazzo G; Drolet NA; Hernandez BE; Oh YS; Patel I; Kim JJ; Zorman B; Patel T; Kamal AHM; Zhao Y; Hicks J; Vasudevan SA; Putluri N; Coarfa C; Sumazin P; Perini G; Parchem RJ; Uribe RA; Barbieri E
Adv Sci (Weinh); 2021 Oct; 8(19):e2005047. PubMed ID: 34365742
[TBL] [Abstract][Full Text] [Related]
2. Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma.
Barbieri E; De Preter K; Capasso M; Chen Z; Hsu DM; Tonini GP; Lefever S; Hicks J; Versteeg R; Pession A; Speleman F; Kim ES; Shohet JM
Cancer Res; 2014 Feb; 74(3):765-74. PubMed ID: 24335960
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
4. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
[TBL] [Abstract][Full Text] [Related]
5. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.
Wu Z; Cui F; Yu F; Peng X; Jiang T; Chen D; Lu S; Tang H; Peng Z
Biochem Biophys Res Commun; 2014 Jun; 449(2):208-15. PubMed ID: 24845563
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity.
Samaraweera L; Grandinetti KB; Huang R; Spengler BA; Ross RA
BMC Cancer; 2014 May; 14():309. PubMed ID: 24885481
[TBL] [Abstract][Full Text] [Related]
8. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; Raschellà G; Melino G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555
[TBL] [Abstract][Full Text] [Related]
9. The embryonic trunk neural crest microenvironment regulates the plasticity and invasion of human neuroblastoma via TrkB signaling.
Kasemeier-Kulesa JC; Spengler JA; Muolo CE; Morrison JA; Woolley TE; Schnell S; Kulesa PM
Dev Biol; 2021 Dec; 480():78-90. PubMed ID: 34416224
[TBL] [Abstract][Full Text] [Related]
10. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
11. Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.
Avci CB; Dodurga Y; Gundogdu G; Caglar HO; Kucukatay V; Gunduz C; Satiroglu-Tufan NL
Tumour Biol; 2013 Dec; 34(6):3853-7. PubMed ID: 23821302
[TBL] [Abstract][Full Text] [Related]
12. Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.
Soriano A; Masanas M; Boloix A; Masiá N; París-Coderch L; Piskareva O; Jiménez C; Henrich KO; Roma J; Westermann F; Stallings RL; Sábado C; de Toledo JS; Santamaria A; Gallego S; Segura MF
Cell Mol Life Sci; 2019 Jun; 76(11):2231-2243. PubMed ID: 30770954
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy.
Vrenken KS; Vervoort BMT; van Ingen Schenau DS; Derks YHW; van Emst L; Grytsenko PG; Middelbeek JAJ; van Leeuwen FN
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165644. PubMed ID: 31862304
[TBL] [Abstract][Full Text] [Related]
14. Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4.
Li D; Song H; Mei H; Fang E; Wang X; Yang F; Li H; Chen Y; Huang K; Zheng L; Tong Q
Nat Commun; 2018 Jul; 9(1):2829. PubMed ID: 30026490
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma differentiation in vivo excludes cranial tumors.
Treffy RW; Rajan SG; Jiang X; Nacke LM; Malkana UA; Naiche LA; Bergey DE; Santana D; Rajagopalan V; Kitajewski JK; O'Bryan JP; Saxena A
Dev Cell; 2021 Oct; 56(19):2752-2764.e6. PubMed ID: 34610330
[TBL] [Abstract][Full Text] [Related]
16. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
17. CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression.
Zheng L; Liang X; Li S; Li T; Shang W; Ma L; Jia X; Shao W; Sun P; Chen C; Jia J
EBioMedicine; 2018 Dec; 38():69-78. PubMed ID: 30449701
[TBL] [Abstract][Full Text] [Related]
18. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of CHAF1A in Epithelial Ovarian Cancer can promote cell proliferation and inhibit cell apoptosis.
Xia D; Yang X; Liu W; Shen F; Pan J; Lin Y; Du N; Sun Y; Xi X
Biochem Biophys Res Commun; 2017 Apr; 486(1):191-197. PubMed ID: 28286267
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma.
Weng Z; Lin J; He J; Gao L; Lin S; Tsang LL; Zhang H; He X; Wang G; Yang X; Zhou H; Zhao H; Li G; Zou L; Jiang X
Neuro Oncol; 2022 Jun; 24(6):872-885. PubMed ID: 34655293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
